Sanofi is to invest 170 million euros to expand a manufacturing facility in France, suggesting the company is confident in the prospects for its vaccines business at a time when its flagship ...

Healthcare company Sanofi (NASDAQ:SNY) to invest more than €1 billion to create new bioproduction capacity at three of its French sites, it said on Monday. These investments at Vitry ...

Sanofi is in discussions with the French government to address concerns officials raised about a potential sale of a controlling stake in the company’s consumer health business, Opella ...

Sanofi's rilzabrutinib receives FDA orphan drug designation for two rare diseases. Clinical studies show meaningful response rates and reduced disease flares.